- Home
- NUVB vs AESI Comparison
NUVB vs AESI Comparison
Compare NUVB & AESI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUVB
- AESI
- Stock Information
- Founded
- NUVB 2018
- AESI 2017
- Country
- NUVB United States
- AESI United States
- Employees
- NUVB N/A
- AESI N/A
- Industry
- NUVB Biotechnology: Pharmaceutical Preparations
- AESI Metal Fabrications
- Sector
- NUVB Health Care
- AESI Industrials
- Exchange
- NUVB Nasdaq
- AESI Nasdaq
- Market Cap
- NUVB 1.1B
- AESI 1.3B
- IPO Year
- NUVB N/A
- AESI 2023
- Fundamental
- Price
- NUVB $5.04
- AESI $10.73
- Analyst Decision
- NUVB Strong Buy
- AESI Buy
- Analyst Count
- NUVB 7
- AESI 8
- Target Price
- NUVB $8.43
- AESI $17.69
- AVG Volume (30 Days)
- NUVB 8.2M
- AESI 2.2M
- Earning Date
- NUVB 11-03-2025
- AESI 11-03-2025
- Dividend Yield
- NUVB N/A
- AESI 9.51%
- EPS Growth
- NUVB N/A
- AESI N/A
- EPS
- NUVB N/A
- AESI 0.12
- Revenue
- NUVB $14,355,000.00
- AESI $1,162,039,000.00
- Revenue This Year
- NUVB $291.13
- AESI $8.43
- Revenue Next Year
- NUVB $332.00
- AESI $4.45
- P/E Ratio
- NUVB N/A
- AESI $92.87
- Revenue Growth
- NUVB 900.35
- AESI 49.18
- 52 Week Low
- NUVB $1.54
- AESI $10.01
- 52 Week High
- NUVB $5.12
- AESI $26.86
- Technical
- Relative Strength Index (RSI)
- NUVB 76.90
- AESI 46.71
- Support Level
- NUVB $3.36
- AESI $10.01
- Resistance Level
- NUVB $3.84
- AESI $10.82
- Average True Range (ATR)
- NUVB 0.29
- AESI 0.48
- MACD
- NUVB 0.11
- AESI 0.00
- Stochastic Oscillator
- NUVB 95.45
- AESI 41.38
About NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.
About AESI Atlas Energy Solutions Inc.
Atlas Energy Solutions Inc is a provider of proppant and logistics services to the oil and natural gas industry within the Permian Basin of West Texas and New Mexico, the most active oil and natural gas basin in North America. Proppant is necessary to facilitate the recovery of hydrocarbons from oil and natural gas wells. One hundred percent of its sand reserves are located in Winkler and Ward Counties, Texas, within the Permian Basin, and its operations consist of proppant production and processing facilities, including two facilities near Kermit, Texas, and a third facility near Monahans, Texas.